ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis

Víctor A. Arrieta, Johnny Duerinck, Kirsten B. Burdett, Karl J. Habashy, Wietse Geens, Andrew Gould, Julia K. Schwarze, Crismita Dmello, Kwang Soo Kim, Ruth Saganty, Li Chen, Alberto Moscona, Matthew McCord, Catalina Lee-Chang, Craig M. Horbinski, Hui Zhang, Roger Stupp, Bart Neyns, Adam M. Sonabend^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Immunology and Microbiology